T lymphocyte activation in myasthenic thymoma

Area of Science:

• Immunology
• Cell Biology

Background:

• Myasthenia gravis (MG) is an autoimmune disorder often associated with thymoma.
• The thymus gland's role in MG pathogenesis, particularly in the presence of thymoma, requires further elucidation.

Purpose of the Study:

• To compare the functional and phenotypic characteristics of lymphocytes from thymoma in MG patients (Th-L) with those from non-thymomatous thymus (NTh-L).
• To investigate the response of Th-L and NTh-L to interleukin-2 (IL-2) in developing lymphokine-activated killer (LAK) and natural killer (NK) activities.
• To analyze phenotypic changes in these lymphocytes during incubation.

Main Methods:

• Lymphocytes were isolated from thymoma (Th-L) and non-thymomatous thymus (NTh-L) of MG patients with thymoma, and NTh-L from MG patients without thymoma.
• Cells were incubated with IL-2 to assess LAK and NK activity.
• Flow cytometry was used to analyze phenotypic changes (CD3+, CD4+, CD8+ cell proportions).

Main Results:

• Both Th-L and NTh-L from MG patients developed LAK and NK activities upon IL-2 stimulation.
• LAK activity was significantly higher in Th-L compared to NTh-L.
• Th-L from MG patients showed increased proportions of CD3+, CD4+/CD8-, and CD4-/CD8+ cells, and a decrease in CD4+/CD8+ cells during incubation, suggesting maturation and enhanced activity.

Conclusions:

• Thymoma-derived lymphocytes (Th-L) exhibit a greater potential to respond to IL-2 and develop LAK activity compared to non-thymoma thymus lymphocytes (NTh-L).
• The observed phenotypic changes in Th-L suggest a role in the immune response within the thymoma microenvironment.
• These findings indicate that Th-L may significantly contribute to the pathogenesis of myasthenia gravis associated with thymoma.